Almost every day we hear about innovative cancer therapies, promising to bring better outcome for our patients. Unfortunately, generating evidence of benefits in clinical trials does not guarantee that valuable innovations also reach patients in daily care. There remains an important gap between the development of new interventions and their implementation in clinical practice.
In this symposium we will discuss how to address this disconnect, which is commonly referred to as ‘the second translational gap’.
Target audience
For everyone interested in bringing the best value to patients: researchers, clinicians, policy makers.
Programme
Organisation: Meet the expert-initiative, Chair ESTRO Value-Based Radiation Oncology – Ghent University
- How an investment in health systems can support us to bridge the second translational gap
Prof. Ajay Aggarwal, MD, PhD, prof. of Cancer Services and Systems Research, London School of Hygiene and Tropical Medicine/Guy’s & St Thomas’ NHS Trust - The politics of global cancer control
Prof. Richard Sullivan, MD, PhD, chair in Cancer Policy and Global Health, director of the Institute of Cancer Policy and co-director of the Centre for Conflict & Health Research, King’s College London
A light lunch will be served.
Practical information
- Registration | The symposium is free, but registering is required. You can register until February 18. Attendance is limited to 70 people and will be given on a first come, first serve basis.
- Accreditation | Ethics and Economy accreditation has been requested.
